Literature DB >> 33546156

Decídetexto: Feasibility and Acceptability of a Mobile Smoking Cessation Intervention in Puerto Rico.

Francisco Cartujano-Barrera1, Cristina I Peña-Vargas2, Evelyn Arana-Chicas1, José G Pérez-Ramos1, Josiemer Mattei3, Alejandra Hurtado-de-Mendoza4, Rosario Costas-Muñiz5, Julio Jiménez2, Ana Paula Cupertino1, Eida M Castro2.   

Abstract

The purpose of this pilot study was to assess the feasibility and acceptability of a mobile smoking cessation intervention in Puerto Rico. This was a single-arm pilot study with 26 smokers in Puerto Rico who were enrolled in Decídetexto, a mobile smoking cessation intervention. Decídetexto incorporates three integrated components: (1) a tablet-based software that collects smoking-related information to develop an individualized quit plan, (2) a 24-week text messaging counseling program with interactive capabilities, and (3) pharmacotherapy support. Outcome measures included self-reported 7-day point prevalence abstinence at Months 3 and 6, pharmacotherapy adherence, satisfaction with the intervention, and changes in self-efficacy. The average age of the participants was 46.8 years (SD 12.7), half of them (53.8%) were female. Most participants (92.3%) smoked daily and half of them (53.8%) used menthol cigarettes. All participants requested nicotine patches at baseline. However, only 13.0% of participants used the patch >75% of days. At Month 3, 10 participants (38.4%) self-reported 7-day point prevalence abstinence (88.5% follow-up rate). At Month 6, 16 participants (61.5%) self-reported 7-day point prevalence abstinence (76.9% follow-up rate). Most participants (90%, 18/20) reported being satisfied/extremely satisfied with the intervention at Month 6. Self-efficacy mean scores significantly increased from 40.4 (SD 12.1) at baseline to 57.9 (SD 11.3) at Month 3 (p < 0.01). The study suggests that Decídetexto holds promise for further testing among Puerto Rican smokers.

Entities:  

Keywords:  Latinos; Puerto Ricans; Puerto Rico; mHealth; smoking; smoking cessation

Year:  2021        PMID: 33546156      PMCID: PMC7913140          DOI: 10.3390/ijerph18041379

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  42 in total

1.  Reach, efficacy, and cost-effectiveness of free nicotine medication giveaway programs.

Authors:  K Michael Cummings; Brian Fix; Paula Celestino; Shannon Carlin-Menter; Richard O'Connor; Andrew Hyland
Journal:  J Public Health Manag Pract       Date:  2006 Jan-Feb

2.  State-specific prevalence of cigarette smoking and smokeless tobacco use among adults --- United States, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-11-05       Impact factor: 17.586

3.  "Vive Sin Tabaco… ¡Decídete!" Feasibility and Acceptability of an e-Health Smoking Cessation Informed Decision-Making Tool Integrated in Primary Healthcare in Mexico.

Authors:  Ana Paula Cupertino; Francisco Cartujano-Barrera; Jaime Perales; Taynara Formagini; Rosibel Rodríguez-Bolaños; Edward F Ellerbeck; Guadalupe Ponciano-Rodríguez; Luz Myriam Reynales-Shigematsu
Journal:  Telemed J E Health       Date:  2018-07-26       Impact factor: 3.536

4.  Smoking cessation among U.S. Hispanic/Latino adults: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Authors:  Cheryl R Merzel; Carmen R Isasi; Garrett Strizich; Sheila F Castañeda; Marc Gellman; Aida L Maisonet Giachello; David J Lee; Frank J Penedo; Krista M Perreira; Robert C Kaplan
Journal:  Prev Med       Date:  2015-10-26       Impact factor: 4.018

5.  Cigarette smoking behavior among US Latino men and women from different countries of origin.

Authors:  E J Pérez-Stable; A Ramirez; R Villareal; G A Talavera; E Trapido; L Suarez; J Marti; A McAlister
Journal:  Am J Public Health       Date:  2001-09       Impact factor: 9.308

Review 6.  Screening for depression.

Authors:  Douglas M Maurer
Journal:  Am Fam Physician       Date:  2012-01-15       Impact factor: 3.292

7.  Decídetexto: Mobile cessation support for Latino smokers. Study protocol for a randomized clinical trial.

Authors:  Francisco Cartujano-Barrera; Evelyn Arana-Chicas; Delwyn Catley; Lisa Sanderson Cox; Francisco J Diaz; Edward F Ellerbeck; Kristi D Graves; Chinwe Ogedegbe; Ana Paula Cupertino
Journal:  Contemp Clin Trials       Date:  2020-10-17       Impact factor: 2.226

8.  Low birthweight and infant mortality in Puerto Rico.

Authors:  J E Becerra; H K Atrash; N Pérez; J A Saliceti
Journal:  Am J Public Health       Date:  1993-11       Impact factor: 9.308

Review 9.  Mobile phone-based interventions for smoking cessation.

Authors:  Robyn Whittaker; Hayden McRobbie; Chris Bullen; Anthony Rodgers; Yulong Gu
Journal:  Cochrane Database Syst Rev       Date:  2016-04-10

10.  Adult tobacco use among racial and ethnic groups living in the United States, 2002-2005.

Authors:  Ralph S Caraballo; Sue Lin Yee; Joe Gfroerer; Sara A Mirza
Journal:  Prev Chronic Dis       Date:  2008-06-15       Impact factor: 2.830

View more
  3 in total

1.  "I'm a transgender man… I have to quit smoking for treatment and surgery": Describing the experience of a Latino transgender man during his attempt to quit smoking.

Authors:  Francisco Cartujano-Barrera; Lisa Sanderson Cox; Delwyn Catley; Zainab Shah; Ash B Alpert; Ana Paula Cupertino
Journal:  Explore (NY)       Date:  2021-11-17       Impact factor: 2.358

2.  Development of a WeChat-based Mobile Messaging Smoking Cessation Intervention for Chinese Immigrant Smokers: Qualitative Interview Study.

Authors:  Nan Jiang; Erin S Rogers; Paula Cupertino; Xiaoquan Zhao; Francisco Cartujano-Barrera; Joanne Chen Lyu; Lu Hu; Scott E Sherman
Journal:  JMIR Form Res       Date:  2022-06-30

3.  Web-delivered Acceptance and Commitment Therapy (ACT) for smoking cessation: Is it engaging and efficacious for US Hispanic/Latinx adult smokers?

Authors:  Diana M Kwon; Margarita Santiago-Torres; Kristin E Mull; Brianna M Sullivan; Michael J Zvolensky; Jonathan B Bricker
Journal:  Prev Med Rep       Date:  2022-08-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.